Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Colley

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Tropical Medicine and Health|November 27, 2014
Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?Daniel G Colley
Tropical Medicine and Infectious Disease|October 3, 2018
When Should the Emphasis on Schistosomiasis Control Move to Elimination?W Evan Secor, Daniel G Colley
Vaccine|January 2, 2016
Workshop report: Schistosomiasis vaccine clinical development and product characteristicsAnnie X Mo, Daniel G Colley
Kisaengch'Unghak Chapchi. the Korean Journal of Parasitology|December 1, 1984
[Immunological Responses By Soluble Egg Antigen Of Schistosoma Mansoni In Mice]Myoung Hee Ahn, Daniel G. Colley
The American Journal of Tropical Medicine and Hygiene|August 8, 2002
Practical and ethical issues in the development of a vaccine against schistosomiasis mansoniCharles W Todd, Daniel G Colley
Parasitology International|April 15, 2004
Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?Daniel G Colley, W Evan Secor
Plos Neglected Tropical Diseases|December 7, 2007
A schistosomiasis research agendaDaniel G Colley, W Evan Secor
The American Journal of Tropical Medicine and Hygiene|May 14, 2020
Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and EvolutionDaniel G Colley, Julie A Jacobson, Sue Binder
Infectious Diseases of Poverty|March 23, 2017
Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?Daniel G Colley, Tamara S Andros, Carl H Campbell
Memorias Do Instituto Oswaldo Cruz|October 16, 2004
Interactions between schistosomiasis and human immunodeficiency virus in Western KenyaW Evan Secor, Diana M S Karanja, Daniel G Colley
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Tropical Medicine and Health|November 27, 2014
Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?Daniel G Colley
Tropical Medicine and Infectious Disease|October 3, 2018
When Should the Emphasis on Schistosomiasis Control Move to Elimination?W Evan Secor, Daniel G Colley
Vaccine|January 2, 2016
Workshop report: Schistosomiasis vaccine clinical development and product characteristicsAnnie X Mo, Daniel G Colley
Kisaengch'Unghak Chapchi. the Korean Journal of Parasitology|December 1, 1984
[Immunological Responses By Soluble Egg Antigen Of Schistosoma Mansoni In Mice]Myoung Hee Ahn, Daniel G. Colley
The American Journal of Tropical Medicine and Hygiene|August 8, 2002
Practical and ethical issues in the development of a vaccine against schistosomiasis mansoniCharles W Todd, Daniel G Colley
Parasitology International|April 15, 2004
Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?Daniel G Colley, W Evan Secor
Plos Neglected Tropical Diseases|December 7, 2007
A schistosomiasis research agendaDaniel G Colley, W Evan Secor
The American Journal of Tropical Medicine and Hygiene|May 14, 2020
Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and EvolutionDaniel G Colley, Julie A Jacobson, Sue Binder
Infectious Diseases of Poverty|March 23, 2017
Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?Daniel G Colley, Tamara S Andros, Carl H Campbell
Memorias Do Instituto Oswaldo Cruz|October 16, 2004
Interactions between schistosomiasis and human immunodeficiency virus in Western KenyaW Evan Secor, Diana M S Karanja, Daniel G Colley
Pageof 8